Company Performance Metrics
INNODIA is a non-profit network that provides research infrastructure and services to accelerate therapy development for type 1 diabetes. The organization coordinates a large European network of accredited clinical trial sites, research laboratories, and diagnostic facilities focused on type 1 diabetes. INNODIA offers a master protocol framework,
clinical trial design support, and operational coordination for intervention and observational studies. It maintains a centralized database and bioresource of biological samples to support biomarker discovery and therapeutic evaluation. The organization provides consulting for medicine developers, research and innovation labs, and diagnostic laboratories on trial implementation and regulatory interaction. INNODIA also engages people living with type 1 diabetes in advisory roles to align study design with patient needs and to support the development of disease-modifying therapies.
